Delivery Order SPE2DB24D3015-SPE2DB24FFXPH
Award Date
9/3/24
Potential Completion Date
9/24/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $7,792.08, is for the supply of the pharmaceutical product Ibrance 125 mg Capsule 21s. The award has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies to provide a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ibrance 125 mg capsules. The $8,118.08 fixed-price contract has a performance period through May 2025 and is not a set-aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 21, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,122.76, is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 24, 2025. The award does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,797.84 firm fixed-price delivery order is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,797.84 firm fixed price delivery order is for IBRANCE 75 MG CAPSULE 21S, a medication, with a period of performance through May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract has an ultimate completion date of October 7, 2024 and a ceiling value of $15,584.16. It is for the supply of the pharmaceutical product Ibrance 125 mg capsule 21s. The contract is not set aside for any specific business type. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $7,792.08 delivery order is for the supply of 4565844290 units of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,796.30 contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a specialty cancer medication. The award has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,118.08 firm fixed-price contract is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The award has an ultimate completion date of July 14, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This award is not set aside and is...